MicroRNA-dependent regulation of transcription in non-small cell lung cancer

PLoS ONE

Volumn 9, Issue 3, 2014, Pages

  Molina Pinelo, Sonia ^a   Gutiérrez, Gabriel ^b   Pastor, Maria Dolores ^a   Hergueta, Marta ^c,l   Moreno Bueno, Gema ^c,l   García Carbonero, Rocío ^a,d   Nogal, Ana ^a,e   Suárez, Rocío ^a   Salinas, Ana ^a   Pozo Rodríguez, Francisco ^f,g   Lopez Rios, Fernando ^h   Agulló Ortuño, Maria Teresa ^f   Ferrer, Irene ^a   Perpiñá, Asunción ⁱ   Palacios, José ^j   Carnero, Amancio ^k   Paz Ares, Luis ^a,d  

^a Instituto de Biomedicina de Sevilla   (Spain)

^b UNIVERSITY OF SEVILLE   (Spain)

^c UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^d HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

^e UNIVERSITY OF PORTO   (Portugal)

^f HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^g INSTITUTO DE SALUD CARLOS III   (Spain)

^h FiHM Centro Integral Oncológico Hospital de Madrid Clara Campal   (Spain)

ⁱ HOSPITAL SEVERO OCHOA   (Spain)

^j HOSPITAL RAMÓN Y CAJAL   (Spain)

^k CSIC   (Spain)

^l HOSPITAL UNIVERSITARIO LA PAZ IDIPAZ   (Spain)

more..

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; MICRORNA; 3' UNTRANSLATED REGION; TUMOR MARKER;

3' UNTRANSLATED REGION; ABCC3 GENE; ACSL5 GENE; ADULT; AGED; ARTICLE; CEACAM6 GENE; CGN GENE; CLDN3 GENE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE; GENE EXPRESSION; HISTOLOGY; HUMAN; HUMAN TISSUE; LUNG NON SMALL CELL CANCER; MALE; MICROARRAY ANALYSIS; MIDDLE AGED; MLPH GENE; MUC1 GENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ANALYSIS; TMEM45B GENE; TRANSCRIPTION REGULATION; ADENOCARCINOMA; COHORT ANALYSIS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENETICS; HUMAN GENOME; LUNG TUMOR; METABOLISM; NON SMALL CELL LUNG CANCER; POLYMERASE CHAIN REACTION; REPORTER GENE; SQUAMOUS CELL CARCINOMA;

3' UNTRANSLATED REGIONS; ADENOCARCINOMA; AGED; BIOMARKERS, TUMOR; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; COHORT STUDIES; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, REPORTER; GENOME, HUMAN; HUMANS; LUNG NEOPLASMS; MALE; MICRORNAS; MIDDLE AGED; POLYMERASE CHAIN REACTION; TRANSCRIPTION, GENETIC;

EID: 84898747210     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0090524     Document Type: Article

References (51)

1. Siegel R, Ward E, Brawley O, Jemal A (2011) Cancer statistics, 2011: The impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin 61: 212-236.
2. Minna JD, Roth JA, Gazdar AF (2002) Focus on lung cancer. Cancer Cell 1: 49-52. (Pubitemid 41039175)
3. Wistuba II (2007) Genetics of preneoplasia: lessons from lung cancer. Curr Mol Med 7: 3-14.
4. Petersen I, Bujard M, Petersen S, Wolf G, Goeze A, et al. (1997) Patterns of chromosomal imbalances in adenocarcinoma and squamous cell carcinoma of the lung. Cancer Res 57: 2331-2335. (Pubitemid 27255883)
5. Kayser G, Csanadi A, Otto C, Plönes T, Bittermann N, et al (2013) Simultaneous multi-antibody staining in non-small cell lung cancer strengthens diagnostic accuracy especially in small tissue samples. PLoS One 8: e56333.
6. Gazdar AF (2009) Activating and resistance mutations of EGFR in non-small-cell lung cancer: role in clinical response to EGFR tyrosine kinase inhibitors. Oncogene 28 Suppl 1: S24-31.
7. Perez-Moreno PD, Brambilla E, Thomas RK, Soria JC (2012) Squamous-cell carcinoma of the lung: molecular subtypes and therapeutic opportunities. Clin Cancer Res 18: 2443-2451.
8. Perez-Soler R (2009) Individualized therapy in non-small-cell lung cancer: future versus current clinical practice. Oncogene 28 Suppl 1: S38-45.
9. Valk K, Vooder T, Kolde R, Reintam MA, Petzold C, et al. (2010) Gene expression profiles of non-small cell lung cancer: survival prediction and new biomarkers. Oncology 79: 283-292.
10. Molina-Pinelo S, Suarez R, Pastor MD, Nogal A, Marquez-Martin E, et al. (2012) Association between the miRNA signatures in plasma and bronchoalveolar fluid in respiratory pathologies. Dis Markers 32: 221-230.
11. Landi MT, Zhao Y, Rotunno M, Koshiol J, Liu H, et al. (2010) MicroRNA expression differentiates histology and predicts survival of lung cancer. Clin Cancer Res 16: 430-441.
12. Yanaihara N, Caplen N, Bowman E, Seike M, Kumamoto K, et al. (2006) Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell 9: 189-198. (Pubitemid 43357945)
13. Yu SL, Chen HY, Chang GC, Chen CY, Chen HW, et al. (2008) MicroRNA signature predicts survival and relapse in lung cancer. Cancer Cell 13: 48-57.
14. Patnaik SK, Kannisto E, Knudsen S, Yendamuri S (2010) Evaluation of microRNA expression profiles that may predict recurrence of localized stage I non-small cell lung cancer after surgical resection. Cancer Res 70: 36-45.
15. Bishop JA, Benjamin H, Cholakh H, Chajut A, Clark DP, et al. (2010) Accurate classification of non-small cell lung carcinoma using a novel microRNA-based approach. Clin Cancer Res 16: 610-619.
16. Fassina A, Cappellesso R, Fassan M (2011) Classification of Non-Small Cell Lung Carcinoma in Trans-Thoracic Needle specimens using microRNA expression Profiling. Chest 140: 1305-1311.
17. Romualdi C, Vitulo N, Del Favero M, Lanfranchi G (2005) MIDAW: a web tool for statistical analysis of microarray data. Nucleic Acids Res 33: W644-649. (Pubitemid 44530001)
18. John B, Enright AJ, Aravin A, Tuschl T, Sander C, et al. (2004) Human MicroRNA targets. PLoS Biol 2: e363.
19. Lewis BP, Burge CB, Bartel DP (2005) Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120: 15-20. (Pubitemid 40094598)
20. Dweep H, Sticht C, Pandey P, Gretz N (2011) miRWalk-database: prediction of possible miRNA binding sites by "walking" the genes of three genomes. J Biomed Inform 44: 839-847.
21. Gibbs S, Silva Pinto AN, Murli S, Huber M, Hohl D, et al. (2000) Epidermal growth factor and keratinocyte growth factor differentially regulate epidermal migration, growth, and differentiation. Wound Repair Regen 8: 192-203. (Pubitemid 30421522)
22. Filipowicz W, Bhattacharyya SN, Sonenberg N (2008) Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight? Nat Rev Genet 9: 102-114.
23. Xing L, Todd NW, Yu L, Fang H, Jiang F (2010) Early detection of squamous cell lung cancer in sputum by a panel of microRNA markers. Mod Pathol 23: 1157-1164.
24. Lebanony D, Benjamin H, Gilad S, Ezagouri M, Dov A, et al. (2009) Diagnostic assay based on hsa-miR-205 expression distinguishes squamous from nonsquamous non-small-cell lung carcinoma. J Clin Oncol 27: 2030-2037.
25. Huang W, Hu J, Yang DW, Fan XT, Jin Y, et al. (2012) Two microRNA panels to discriminate three subtypes of lung carcinoma in bronchial brushing specimens. Am J Respir Crit Care Med. 186: 1160-1167.
26. Ring BZ, Seitz RS, Beck RA, Shasteen WJ, Soltermann A, et al. (2009) A novel five-antibody immunohistochemical test for subclassification of lung carcinoma. Mod Pathol 22: 1032-1043.
27. Mukhopadhyay S, Katzenstein AL (2011) Subclassification of non-small cell lung carcinomas lacking morphologic differentiation on biopsy specimens: Utility of an immunohistochemical panel containing TTF-1, napsin A, p63, and CK5/6. Am J Surg Pathol 35: 15-25.
28. Blumenthal RD, Hansen HJ, Goldenberg DM (2005) Inhibition of adhesion, invasion, and metastasis by antibodies targeting CEACAM6 (NCA-90) and CEACAM5 (Carcinoembryonic Antigen). Cancer Res 65: 8809-8817. (Pubitemid 41377369)
29. Schneeberger EE, Lynch RD (2004) The tight junction: a multifunctional complex. Am J Physiol Cell Physiol 286: C1213-1228. (Pubitemid 38649971)
30. Matter K, Aijaz S, Tsapara A, Balda MS (2005) Mammalian tight junctions in the regulation of epithelial differentiation and proliferation. Curr Opin Cell Biol 17: 453-458. (Pubitemid 41267158)
31. Shin K, Fogg VC, Margolis B (2006) Tight junctions and cell polarity. Annu Rev Cell Dev Biol 22: 207-235.
32. Logsdon CD, Simeone DM, Binkley C, Arumugam T, Greenson JK, et al. (2003) Molecular profiling of pancreatic adenocarcinoma and chronic pancreatitis identifies multiple genes differentially regulated in pancreatic cancer. Cancer Res 63: 2649-2657. (Pubitemid 36605209)
33. Scholzel S, Zimmermann W, Schwarzkopf G, Grunert F, Rogaczewski B, et al. (2000) Carcinoembryonic antigen family members CEACAM6 and CEACAM7 are differentially expressed in normal tissues and oppositely deregulated in hyperplastic colorectal polyps and early adenomas. Am J Pathol 156: 595-605. (Pubitemid 30643815)
34. Blumenthal RD, Leon E, Hansen HJ, Goldenberg DM (2007) Expression patterns of CEACAM5 and CEACAM6 in primary and metastatic cancers. BMC Cancer 7: 2.
35. Hammarstrom S (1999) The carcinoembryonic antigen (CEA) family: structures, suggested functions and expression in normal and malignant tissues. Semin Cancer Biol 9: 67-81.
36. Jantscheff P, Terracciano L, Lowy A, Glatz-Krieger K, Grunert F, et al. (2003) Expression of CEACAM6 in resectable colorectal cancer: a factor of independent prognostic significance. J Clin Oncol 21: 3638-3646. (Pubitemid 46594057)
37. Duxbury MS, Ito H, Zinner MJ, Ashley SW, Whang EE (2004) CEACAM6 gene silencing impairs anoikis resistance and in vivo metastatic ability of pancreatic adenocarcinoma cells. Oncogene 23: 465-473. (Pubitemid 38175001)
38. van der Deen M, de Vries EG, Timens W, Scheper RJ, Timmer-Bosscha H, et al. (2005) ATP-binding cassette (ABC) transporters in normal and pathological lung. Respir Res 6: 59.
39. Gottesman MM, Fojo T, Bates SE (2002) Multidrug resistance in cancer: role of ATP-dependent transporters. Nat Rev Cancer 2: 48-58. (Pubitemid 37328807)
40. O'Brien C, Cavet G, Pandita A, Hu X, Haydu L, et al. (2008) Functional genomics identifies ABCC3 as a mediator of taxane resistance in HER2-amplified breast cancer. Cancer Res 68: 5380-5389.
41. Tran QN (2013) A novel method for finding non-small cell lung cancer diagnosis biomarkers. BMC Med Genomics 6 Suppl 1: S11.
42. Kufe DW (2009) Mucins in cancer: function, prognosis and therapy. Nat Rev Cancer 9: 874-885.
43. McGuckin MA, Walsh MD, Hohn BG, Ward BG, Wright RG (1995) Prognostic significance of MUC1 epithelial mucin expression in breast cancer. Hum Pathol 26: 432-439.
44. Guddo F, Giatromanolaki A, Koukourakis MI, Reina C, Vignola AM, et al. (1998) MUC1 (episialin) expression in non-small cell lung cancer is independent of EGFR and c-erbB-2 expression and correlates with poor survival in node positive patients. J Clin Pathol 51: 667-671. (Pubitemid 28423725)
45. Giatromanolaki A, Koukourakis MI, Sivridis E, O'Byrne K, Cox G, et al. (2000) Coexpression of MUC1 glycoprotein with multiple angiogenic factors in non-small cell lung cancer suggests coactivation of angiogenic and migration pathways. Clin Cancer Res 6: 1917-1921. (Pubitemid 30305090)
46. Gao J, McConnell MJ, Yu B, Li J, Balko JM, et al. (2009) MUC1 is a downstream target of STAT3 and regulates lung cancer cell survival and invasion. Int J Oncol 35: 337-345.
47. Ren J, Agata N, Chen D, Li Y, Yu WH, et al. (2004) Human MUC1 carcinoma-associated protein confers resistance to genotoxic anticancer agents. Cancer Cell 5: 163-175. (Pubitemid 38283802)
48. Yamashita Y, Kumabe T, Cho YY, Watanabe M, Kawagishi J, et al. (2000) Fatty acid induced glioma cell growth is mediated by the acyl-CoA synthetase 5 gene located on chromosome 10q25.1-2q25.2, a region frequently deleted in malignant gliomas. Oncogene 19: 5919-5925. (Pubitemid 32005373)
49. Mashima T, Oh-hara T, Sato S, Mochizuki M, Sugimoto Y, et al. (2005) p53-defective tumors with a functional apoptosome-mediated pathway: a new therapeutic target. J Natl Cancer Inst 97: 765-777. (Pubitemid 40872382)
50. Matesic LE, Yip R, Reuss AE, Swing DA, O'Sullivan TN, et al. (2001) Mutations in Mlph, encoding a member of the Rab effector family, cause the melanosome transport defects observed in leaden mice. Proc Natl Acad Sci U S A 98: 10238-10243. (Pubitemid 32803004)
51. Chang HH, Dreyfuss JM, Ramoni MF (2011) A transcriptional network signature characterizes lung cancer subtypes. Cancer 117: 353-360.